Certified by Founder
Lodge
Broadview Ventures Inc
investor
United States
- Boston, MA
- 09/12/2022
- Series A
- $15,100,000
Broadview Ventures is a mission-driven investment organization. Its primary investment goal is to improve human health in the areas of cardiovascular disease and stroke. We define success as improving human health by bringing innovative technologies to patients.
- Industry Venture Capital and Private Equity Principals
- Website https://broadviewventures.org/
- LinkedIn https://www.linkedin.com/company/broadview-ventures-inc/
Zero Homes | $16,800,000 | (Feb 19, 2026)
Rainfall Health | $15,000,000 | (Feb 19, 2026)
inKind | $450,000,000 | (Feb 19, 2026)
Sift Biosciences | $3,700,000 | (Feb 19, 2026)
Avantos.ai | $25,000,000 | (Feb 19, 2026)
Korsana Biosciences | $175,000,000 | (Feb 19, 2026)
Vervesemi | $10,000,000 | (Feb 19, 2026)
Efficient Computer | $60,000,000 | (Feb 19, 2026)
DG Matrix | $60,000,000 | (Feb 19, 2026)
Synchrony Medical | $5,000,000 | (Feb 19, 2026)
Dataro | $14,280,000 | (Feb 18, 2026)
The Compression Company | $3,400,000 | (Feb 18, 2026)